NCT05469503 - Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure | Biotech Hunter

Enrollment

410

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions

PrehypertensionElevated Blood PressureBlood PressureMetabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

TOTUM-854

12 weeks of TOTUM-854 supplementation

DIETARY_SUPPLEMENT

Placebo

12 weeks of placebo supplementation

Trial Locations (10)

Multiprofile Hospital for Active Treatment Cardiology Department, Haskovo

Multiprofile Hospital for Active Treatment - Uni Hospital OOD, Cardiology Department, Panagyurishte

Diagnostic Consultative Center VII-Plovdiv South district EOOD, Cabinet of Endocrinology, Plovdiv

Multiprofile Hospital for Active Treatment Sveta Karidad EAD, Cardiology Department, Plovdiv

Diagnostic Consultative Center XX- Sofia EOOD, Sofia

CHU Clermont Ferrand PIC/CIC Inserm 1405, Clermont-Ferrand

Vitamed Gałaj i Cichomski sp.j, Bydgoszcz

Centrum Medyczne Linden, Krakow

"Przychodnia Zespołu Lekarza Rodzinnego Medyk", Słupca

Centrum Medyczne Oporów, Wroclaw